Back to Search
ANDREW MAI, MD
MD
Diagnostic Radiology Physician
NPI: 1871736322IndividualAccepts Medicare
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
ME125190(FL)
CMS Specialties
PrimaryDIAGNOSTIC RADIOLOGY
Education
LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN NEW ORLEANS
Class of 2009
Research & Publications (20)
The anti-apoptotic activity of BAG3 is restricted by caspases and the proteasome.
PMID 19352495·PLoS One·2009
8-other
Chiral HPLC separation and absolute configuration of novel S-DABO derivatives.
PMID 18780368·Chirality·2009
8-other
Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyltransferases.
PMID 19144517·Bioorg Med Chem Lett·2009
8-other
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes.
PMID 19498465·EMBO Rep·2009
7-preclinical
Pyrrole-based hydroxamates and 2-aminoanilides: histone deacetylase inhibition and cellular activities.
PMID 19504533·ChemMedChem·2009
8-other
Non-cancer uses of histone deacetylase inhibitors: effects on infectious diseases and beta-hemoglobinopathies.
PMID 19355991·Curr Top Med Chem·2009
6-review
Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors.
PMID 19663498·J Med Chem·2009
7-preclinical
"Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence.
PMID 19486542·Retrovirology·2009
8-other
PKCepsilon regulation of an alpha5 integrin-ZO-1 complex controls lamellae formation in migrating cancer cells.
PMID 19567915·Sci Signal·2009
8-other
Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.
PMID 19060927·Oncogene·2009
7-preclinical
Histone acetyltransferase inhibitors and preclinical studies.
PMID 19473103·Expert Opin Ther Pat·2009
6-review
New pyrrole-based histone deacetylase inhibitors: binding mode, enzyme- and cell-based investigations.
PMID 18834955·Int J Biochem Cell Biol·2009
8-other
Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead.
PMID 18790076·Int J Biochem Cell Biol·2009
6-review
HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment.
PMID 19047631·Proc Natl Acad Sci U S A·2008
7-preclinical
Identification of long chain alkylidenemalonates as novel small molecule modulators of histone acetyltransferases.
PMID 18434144·Bioorg Med Chem Lett·2008
8-other
Substrate-induced stable enzyme-inhibitor complex formation allows tight binding of novel 2-aminopyrimidin-4(3H)-ones to drug-resistant HIV-1 reverse transcriptase mutants.
PMID 18465760·ChemMedChem·2008
8-other
Histone deacetylase inhibitors and hemoglobin F induction in beta-thalassemia.
PMID 18617435·Int J Biochem Cell Biol·2008
6-review
5-Alkyl-6-benzyl-2-(2-oxo-2-phenylethylsulfanyl)pyrimidin-4(3H)-ones, a series of anti-HIV-1 agents of the dihydro-alkoxy-benzyl-oxopyrimidine family with peculiar structure-activity relationship profile.
PMID 18630898·J Med Chem·2008
8-other
HDAC-class II specific inhibition involves HDAC proteasome-dependent degradation mediated by RANBP2.
PMID 18691615·Biochim Biophys Acta·2008
8-other
Specific activity of class II histone deacetylases in human breast cancer cells.
PMID 19074835·Mol Cancer Res·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3501 JOHNSON ST
HOLLYWOOD, FL 33021 - Phone
- (954) 437-4800
Quick Facts
- NPI
- 1871736322
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 17
- Publications
- 20
Are you this provider?
Claim Your Profile